Why Pfizer's 2017 Was Mediocre at Best Post author:Sam Post published:December 12, 2017 Post category:BioPharma Pfizer’s 2017 wasn’t horrible. Just ho-hum. Source: BioSpace You Might Also Like Amicus Releases More Impressive Pompe Disease Data at WORLDSymposium February 7, 2018 Vertex Quietly Terminates a Small Phase II CF Trial September 11, 2017 Former Celator CPA Connived With Two Friends, Father on Insider-Trading Scheme August 31, 2017
